CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities
Net income (loss) before adjustment for non-controlling interest	$ (2,346,808)	$ (8,453,392)
Income (loss) from discontinued operations, net of tax	12,464,445	(5,323,630)
Income (loss) from continuing operations	(14,811,253)	(3,129,762)
Adjustments to reconcile net loss from continuing operations to cash   used in operating activities, net of acquisitions
Stock based compensation expense	612,626	490,958
Depreciation and amortization	439,653	375,790
Income tax benefit	0	0
Gain on forgiveness of debt	(4,222,000)	0
Loss on sale of assets	1,927	124,090
Bad debt expense	629,791	(9,875)
Increase (decrease) in fair value of derivative warrant liability	11,380,122	(1,844,369)
Loss (gain) on commodity derivative contracts	2,204,606	(4,489,355)
Net cash settlements on commodity derivatives	(1,998,707)	5,484,734
Amortization of debt discount and deferred costs	37,500	47,826
Changes in operating assets and liabilities, net of effect of acquisition
Accounts receivable and other receivables	(1,513,058)	206,352
Inventory	(911,980)	1,008,343
Prepaid expenses and other current assets	(3,232,253)	(1,186,023)
Accounts payable	3,184,965	1,729,129
Accrued expenses	1,203,283	(1,207,230)
Other assets	(699,999)	(581,534)
Net cash used by operating activities	(7,694,777)	(2,980,926)
Cash flows from investing activities
Acquisition of business, net of cash	2,058	(1,822,690)
Internally developed software	0	(49,229)
Purchase of fixed assets	(1,060,039)	(642,186)
Deposit for Refinery Purchase	(10,000,000)	0
Proceeds from sale of fixed assets	74,991	36,465
Net cash used in investing activities	(10,982,990)	(2,477,640)
Cash flows from financing activities
Payments on finance leases	(91,893)	(93,438)
Proceeds from exercise of options and warrants to common stock	6,492,759	0
Distributions to noncontrolling interest	(169,368)	0
Contributions received from noncontrolling interest and redeemable noncontrolling interest	2,260	21,000,000
Line of credit (payments) proceeds, net	(166,129)	0
Proceeds from note payable (includes proceeds from PPP note)	10,078,115	7,992,346
Payments on note payable	(3,778,589)	(12,601,976)
Net cash provided by financing activities	12,367,155	16,296,932
Discontinued operations:
Net cash provided (used) by operation activities	11,014,236	4,370,152
Net cash used in investing activities	(3,168,865)	(3,527,980)
Net cash provided (used) by financing activities	(317,226)	(227,259)
Net cash provided by discontinued operations	7,528,145	614,913
Net change in cash, cash equivalents and restricted cash	1,217,533	11,453,279
Cash, cash equivalents, and restricted cash at beginning of the period	10,995,169	4,199,825
Cash, cash equivalents, and restricted cash at end of period	12,212,702	15,653,104
SUPPLEMENTAL INFORMATION
Cash paid for interest	843,523	812,887
Cash paid for taxes	0	0
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Exchanges of Series B Preferred Stock into common stock	4,747,250	0
Accretion of discount on Series B and B1 Preferred Stock	507,282	1,500,395
Dividends-in-kind accrued on Series B and B1 Preferred Stock	(258,138)	1,296,493
Option exercised	650	0
Equipment acquired under finance leases	0	1,017,638
Initial adjustment of carrying amount redeemable noncontrolling interests	0	9,091,068
Accretion of redeemable noncontrolling interest to redemption value	1,176,683	13,635,797
Series A Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Series A, B and B1 Preferred Stock into Common Stock	34	0
Series B Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Series A, B and B1 Preferred Stock into Common Stock	8,446,836	0
Series B1 Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Series A, B and B1 Preferred Stock into Common Stock	$ 12,046,441	$ 3,368,474